» Articles » PMID: 17725541

Utility of the F98 Rat Glioma Model for Photodynamic Therapy

Overview
Publisher Begell House
Date 2007 Aug 30
PMID 17725541
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A syngeneic rat brain tumor model consisting of F98 glioma cells in Fischer rats was investigated for its utility in PDT studies. Results of in vitro studies demonstrated that the F98 cell line was sensitive to ALA-PDT, especially at low light irradiances. Histological examination revealed that F98 tumors share many fundamental characteristics with human GBMs, including rapid growth and infiltrative behavior. ALA-PDT in normal brain showed that high light fluences (26 J) delivered at relatively low powers (10 mW) are capable of causing significant edema. These findings suggest that light irradiation parameters should be chosen carefully when treating tumor-bearing animals. Rats inoculated with F98 cells preincubated in ALA showed a significant survival advantage following light exposure. Taken together, the results suggest that the F98 rat glioma model is appropriate for PDT studies of malignant gliomas.

Citing Articles

Limiting glioma development by photodynamic therapy-generated macrophage vaccine and allo-stimulation: an in vivo histological study in rats.

Madsen S, Christie C, Huynh K, Peng Q, Uzal F, Krasieva T J Biomed Opt. 2018; 23(2):1-7.

PMID: 29417766 PMC: 5802332. DOI: 10.1117/1.JBO.23.2.028001.


Focused ultrasound-mediated sonochemical internalization: an alternative to light-based therapies.

Gonzales J, Nair R, Madsen S, Krasieva T, Hirschberg H J Biomed Opt. 2016; 21(7):78002.

PMID: 27448101 PMC: 5996869. DOI: 10.1117/1.JBO.21.7.078002.


Photochemical internalization of bleomycin for glioma treatment.

Mathews M, Blickenstaff J, Shih E, Zamora G, Vo V, Sun C J Biomed Opt. 2012; 17(5):058001.

PMID: 22612148 PMC: 3381024. DOI: 10.1117/1.JBO.17.5.058001.


Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Madsen S, Mathews M, Angell-Petersen E, Sun C, Vo V, Sanchez R J Neurooncol. 2008; 91(2):141-9.

PMID: 18777009 PMC: 4116194. DOI: 10.1007/s11060-008-9692-4.